Tag archive for ‘Pluristem Therapeutics’
Jewish Business News On Monday, August 10th, 2020

Can a COVID-19 Cure Come From The Placenta? Pluristem begins trial in Germany

Israeli Biotechnology Company Pluristem Therapeutics is expanding to Europe in search for a cure for COVID-19. The German Ministry of Health Paul Ehrlich Institute (PEI) has approved the protocol for a Phase More...

Shlomi Ella On Thursday, August 1st, 2019

Israeli Scientific Breakthrough: Vaccine for Acute Radiation Poisoning

Israeli placenta-based cell therapy developer Pluristem announced on Wednesday that it had developed a highly effective vaccine against acute radiation poisoning. The company together with the US Department More...

Jewish Business News On Thursday, December 22nd, 2016

U.S-Israel Bird Foundation to invest $7.2 million in 8 new projects

  The Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation approved $7.2 million in funding for eight new projects. In addition to the grants from BIRD, the projects will access More...

Jewish Business News On Sunday, December 6th, 2015

Japan pins hopes on Israeli stem-cell tech

  Four years after Japan’s Fukushima nuclear plant disaster, Fukushima Medical University’s Global Medical Science Center has signed a memorandum of understanding with Israel’s Pluristem Therapeutics More...

Israeli Co Pluristem and Korea’s CHA Move Forward on Strategic Partnership Agreement of $10.4 Million

– Israeli Stem cell developer Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) and Korea’sCHA Bio&Diostech (Kodaq: CHA) are moving forward with the strategic partnership agreement reached More...

Pluristem Signs Korean Licensing Deal : Includes $10 million Share Swap

– – The Israeli stem cell company, Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) has signed a strategic partnership and exclusive licensing agreement with South Korea’s Cha Bio&Diostech More...

Wordpress site Developed by Fixing WordPress Problems